How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
Frequent MRI May Spot Active Secondary Progressive MS More Quickly "If you rely on having a clinical relapse, you may wait a long time" Oct 19, 2021
HCQ and MS; Guillain-Barre and COVID Vax; Neural Fingerprints Can Tell Who You Are News and commentary from the world of neurology and neuroscience Oct 19, 2021
COVID Vaccine Response Varies With MS Treatment Type How this relates to infection outcomes or risk of infecting others is unknown Oct 18, 2021
Quitting Smoking Tied to Slower Motor Decline in Multiple Sclerosis Analysis suggests smoking cessation has benefits in MS Oct 17, 2021
Slowly Expanding Lesions in MS Reduced With BTK Inhibitor Evobrutinib shows effect on marker of chronic inflammation Oct 17, 2021
Virtual Care May Help Multiple Sclerosis Patients Even After the Pandemic Early study paves the way to look at how telehealth may fit into MS care Oct 15, 2021
Novel Anti-CD20 Drug Shows Promise in Relapsing MS Ublituximab bests teriflunomide in head-to-head phase III trials Oct 14, 2021
Guillain-Barré and COVID; Head-to-Head Alzheimer's Blood Tests; Fastball EEG News and commentary from the world of neurology and neuroscience Sep 28, 2021
BTK Inhibitor Reduces New Lesions in Relapsing Multiple Sclerosis Tolebrutinib may hold promise for progressive MS, too Sep 03, 2021
Breast Cancer and MS: New Data Shed Light on Survival Study compares breast cancer patients with and without MS May 19, 2021
BTK Inhibitor Cuts Marker of Neuronal Damage in Relapsing MS Novel agent lowered neurofilament light chain levels, may help reduce neuroaxonal damage Apr 22, 2021
Black MS Patients See More Rapid B-Cell Repopulation May have implications for timing of lab draws and anti-CD20 dosing, researchers say Apr 20, 2021
COVID Antibody Responses Reduced in Some MS Patients But T-cell responses were similar, even in patients on ocrelizumab Apr 19, 2021
Novel Device OK'd to Treat MS Gait Deficits Tongue stimulator generates pulses to combat ataxia Mar 26, 2021
Bacon and Dementia Risk; Zinc Fingers and Tau; Older Adults Light Up News and commentary from the world of neurology and neuroscience Mar 23, 2021
'They Stopped Treating and the Effect Persisted': What We Heard This Week Quotable quotes from 's sources Mar 21, 2021
COVID Outcomes Worse for MS Patients With Mobility Problems North American study also finds higher risk with certain treatments Mar 19, 2021
PML Reported in Ocrelizumab-Treated MS Patient Case raises questions about treatments for older people with multiple sclerosis Mar 16, 2021
Real-World Study Shows MS Patients Have High Infection Risks Urinary, kidney infections especially are more common for people with MS than others Mar 02, 2021
Juggling COVID Vax, MS Therapies Proves Challenging The issue: some multiple sclerosis drugs may attenuate antibody responses to vaccination Mar 01, 2021
Worse COVID-19 Outcomes Tied to MS Disability, Age North American data echoes findings from around the world Feb 28, 2021
Multiple Sclerosis and Depression: Are Links Causal? Mendelian randomization study says no, but predisposition to obesity may play a role Feb 28, 2021
Blood Biomarker Linked with MS Disability, Brain Atrophy Diabetes, smoking, BMI may influence serum NfL, real-world study suggests Feb 27, 2021
Telemedicine Gets Thumbs Up, MS Specialists Say Most providers want to keep using it, but limitations need to be resolved Feb 27, 2021
Sleep-Dementia Link; Neanderthal Mini-Brains; MS Tx and COVID Vax News and commentary from the world of neurology and neuroscience Feb 16, 2021
Study Reassures on MS Patients' Breast, Colorectal Cancer Risk But higher incidence of other cancers in Canadian data Nov 25, 2020
Pregnancies, Later Menopause Tied to Progressive MS Onset Age Pregnancies may have a dose effect on delaying progressive MS Nov 23, 2020
Long-Term Ocrelizumab Benefits Seen in PPMS No new safety signals, but more research needed about anti-CD20 drugs and COVID-19 Nov 02, 2020
Some MS Drugs Linked With Worse COVID-19 Outcomes Registry data looks at risks of hospitalization, ICU admission, ventilation Sep 28, 2020
COVID-19 Hits Black MS Patients Hard COViMS registry gives first look at outcomes among North American patients Sep 28, 2020
Masitinib Shows Positive Signs in Progressive MS Tyrosine kinase inhibitor targets innate immune system Sep 14, 2020
Depression, Suicidal Thoughts Prevalent in MS Burden equally high in relapsing-remitting and progressive multiple sclerosis Sep 13, 2020
Can Tau Predict Early MS Disability? Multiple sclerosis patients with higher baseline tau had worse prognosis, longitudinal study shows Sep 12, 2020
Dementia Tied to Olfaction; Preclinical Alzheimer's Trial; Guillain-Barré and COVID-19 News and commentary from the world of neurology and neuroscience Jul 21, 2020
The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
Muddy Results for MS Hookworm Therapy No significant benefit on MRI, but T regulatory cells increased Jun 15, 2020
Air Quality Tied to MS Risk Multiple sclerosis was more prevalent in Italian areas with more pollution May 29, 2020
